secwatch / observer
8-K/A filed August 11, 2023, 7:59 PM ET ticker RXRX CIK 0001601830
other confidence high sentiment neutral materiality 0.10

Recursion adopts annual Say-on-Pay vote after shareholder majority

RECURSION PHARMACEUTICALS, INC.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.7

RECURSION PHARMACEUTICALS, INC. shareholders approved Advisory vote on frequency of future shareholder advisory votes regarding named executive officer compensation at the 2023-06-16 meeting.

Proposal
say on pay frequency
Outcome
passed
Meeting
2023-06-16
Exact text from the filing
Consistent with the recommendation of the Company’s Board of Directors (the “Board”), a majority of the votes at the Annual Meeting were cast in favor of conducting advisory Say-on-Pay votes on an annual basis.
View on SEC.gov

211 shareholder votes filed in the last 30 days. Browse all shareholder votes →

RECURSION PHARMACEUTICALS, INC. filing history →

Source: SEC EDGAR
accession 0001601830-23-000061
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.